12/31/2023 0 Comments Emc stock news![]() "We are proud to work with partners like EMC who have built a substantial business selling into the numerous departments of the U.S. ![]() We have already seen interest from federal networks for these products and are excited to use our experience working with federal customers to distribute Microcyn," said Eric Bailey, CEO and President of EMC Pharma. "This is a major step that will allow us to sell Microcyn technology products into the federal supply chain. The DAPA approval process was a coordinated effort by Sonoma and EMC Pharma and resulted in obtaining DAPA # SP0200-22-H-0034 for Sonoma's Microcyn Rx products including wound care, prescription dermatology products, Celacyn ® and Levicyn ®, and prescription eye care Acuicyn ®. EMC Pharma is a 100% minority-owned and a certified Minority Business Enterprise (MBE). government entities, including VA hospitals, the Department of Defense, the Federal Bureau of Prisons, as well as state and local prison systems. Approximately half of EMC Pharma's customers are U.S. government is the world's largest purchaser of good and services. ![]() The DAPA enables our partner, EMC Pharma, to enter into distribution agreements for Microcyn® Rx products with federal customers. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including dermatology, eye, oral and nasal care, and wound care, today announced that Microcyn ® Rx products have received a Distribution and Pricing Agreement (DAPA) for distribution by the Defense Logistics Agency (DLA). BOULDER, CO / ACCESSWIRE / Janu/ Sonoma Pharmaceuticals, Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |